DarioHealth Corp (DRIO)

[Penny Speculator]

Sure, here's links to all patent info.

From my following post:
DRIO's Blood Glucose Monitoring Device Patent Info

LabStyle Innovations Receives U.S. Notice of Allowance for Key Patent Relating to the Dario™ Blood Glucose Monitoring Device

May 1, 2014 6:04 am

Critical intellectual property recognition is a major step in bringing Dario™ to market in the U.S.

CAESAREA, Israel, May 1, 2014 /PRNewswire/ – LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for core patent claims covering the company’s personalized blood glucose monitoring device.

LabStyle’s now patent pending invention, entitled “FLUID TESTING APPARATUS AND METHODS OF USE”, specifically relates to how the Dario™ blood glucose monitor draws power from and transmits data to a smart phone via the audio jack port. This device is designed to work in tandem with LabStyle’s novel and powerful Dario™ software application to form the overall Dario™ Diabetes Management Solution.

The issuance of the Notice of Allowance is the critical milestone that will allow LabStyle to obtain formal U.S. patent protection in the coming months for this invention while LabStyle continues to seek similar patent protection in non-U.S. jurisdictions. LabStyle also believes that the claims of this invention could potentially be expanded to cover the measurement of parameters to help manage additional chronic diseases.

Erez Raphael, LabStyle’s President and Chief Executive Officer, stated “This is a major milestone for our company and an important recognition of the truly novel nature of our Dario product offering. Dario is the world’s first personalized smart meter and is already changing the way people manage their diabetes in our initial launch jurisdictions. This patent allowance validates our efforts in developing cutting edge products that help people manage their diabetes and thrive. Further, this patent will greatly strengthen our competitive position in the U.S. assuming FDA approval of Dario. Importantly, the allowed claims underscore our ownership of this technology and cover our methodology that has been based upon our extensive database of reference feedback, close customer collaboration, and innovative product engineering and development. We’re extremely proud to have achieved this distinction.”

In September 2013, LabStyle received CE mark certification for the Dario™ personalized smart meter (Dario™ Blood Glucose Monitoring System) and began a world rollout in select countries. LabStyle filed a Premarket Notification Application, also known as a 510(k), with the US Food and Drug Administration (FDA) for Dario™ inDecember 2013 and is expecting a response from FDA later this year.

Quoted Source: myDario.com (Published May 1 2014)

Dario™ Blood Glucose Monitoring Device:


Blood Glucose Cartridge Patent:
United States Design Patent No.: US D706,934 S
Claims: "The ornamental design for a blood glucose cartridge, as shown and described."
Assignee: Labstyle Innovation Ltd. (Caesarea, IL)
Filed: Jan. 24, 2013
Date of Patent: Jun. 10, 2014
Source Link: Click Here via USPTO.gov
Full Text Link: Click Here via USPTO.gov
PDF Link: Click Here via USPTO.gov

Glucose Meter Patent:
United States Design Patent No.: US D706,935 S
Claims: "The ornamental design for a glucose meter, as shown and described."
Assignee: Labstyle Innovation Ltd. (Caesarea, IL)
Filed: Jan. 24, 2013
Date of Patent: Jun. 10, 2014
Source Link: Click Here via USPTO.gov
Full Text Link: Click Here via USPTO.gov
PDF Link: Click Here via USPTO.gov

Fluid Testing Apparatus And Methods Of Use Patent:
United States Patent No.: US 8,797,180 B2
Abstract: "The invention is directed to a mobile hand held miniature laboratory system in general, and to fluid testing apparatus for performing a parameter measurement in a fluid sample and methods of use in particular. The apparatus comprising: a strip adapted to absorb a fluid sample and to produce a signal indicative of the parameter level in the sample; and adaptor adapted to connect the strip to a smart phone to allow delivery of the produced signal or a correlated signal to the smart phone for obtaining a measurement of the fluid parameter displayed on the smart phone, wherein the testing apparatus relies on the smart phone at least for power supply and display device. The fluid may be a physiological fluid such as blood, urine, saliva or amniotic fluid, or a non-physiological fluid such as fluid obtained from industrial pools for fish or algae growth, or entertainment swimming pools."
Assignee: Labstyle Innovation Ltd. (Caesarea, IL)
Filed: Feb. 10, 2013
Date of Patent: Aug. 5, 2014
Source Link: Click Here via USPTO.gov
Full Text Link: Click Here via USPTO.gov
PDF Link: Click Here via USPTO.gov

My Opinion:
LabStyle's core patent claims covering the company’s personalized blood glucose monitoring device is HUGE, as it can be and will be EXPANDED to cover the measurement of parameters to help manage ADDITIONAL chronic diseases, AND/OR even be expanded for NON human testing purposes, as the patent STATES, "The fluid may be a physiological fluid such as blood, urine, saliva or amniotic fluid, or a non-physiological fluid such as fluid obtained from industrial pools for fish or algae growth, or entertainment swimming pools."
The future possibilities here are astounding!